Royal Agrifirm Group has reached an agreement to acquire Hamlet Protein, a global leader in specialty soy-based protein ingredients for young animal nutrition. The transaction is expected to close in the coming weeks, subject to customary conditions.
This acquisition is an important step in expanding the Specialties business of Royal Agrifirm Group, which provides high-value nutritional solutions and technical services to the feed industry.
Its portfolio includes advanced premixes, concentrates, functional feed ingredients, farm minerals and young animal nutrition concepts that help feed manufacturers and integrators improve animal performance, consistency, and efficiency.
Hamlet Protein is widely recognized for its highly digestible soy-based ingredients that promote gut health and consistent early-life performance. Its patented technology ensures reliable and consistent quality, which is crucial for feed manufacturers.
Hamlet Protein employs around 115 people and operates production facilities in Denmark and the US and a sales office in China, serving customers worldwide.
Integrating Hamlet Protein’s capabilities with Royal Agrifirm Group’s nutritional expertise and global network strengthens the combined offering for early-life nutrition.
Royal Agrifirm Group CEO Piet Hilarides said the acquisition aligns completely with the company’s mission.
“Hamlet Protein’s proven technology strengthens our ability to help customers achieve optimal animal health and performance throughout the life cycle, driven by our shared focus on early feeding. This fits directly with our purpose of contributing to a responsible food chain for future generations,” he explained.
Hamlet Protein’s current owner, Altor, expressed confidence in the transition.
Søren Johansen, Senior Partner at Altor, said the agreement places Hamlet Protein with the right long-term partner. “Agrifirm’s focus on specialty nutrition, and its international presence create an excellent platform for Hamlet Protein to further scale its technology and impact,” he added.
For Royal Agrifirm Group’s Specialties business, the acquisition expands both technological capabilities and market relevance.
Bas van Driel, Group Director Specialties at Royal Agrifirm Group, said “Hamlet Protein is a strong addition to our strategy of bringing differentiated, science-based concepts to our valued customers and partners in the feed industry worldwide. Their early-life protein solutions and know-how allow us to develop more integrated nutritional concepts that support customers in achieving consistent performance and improved feed efficiency.”
Hamlet Protein CEO Erik Visser highlighted the opportunity for growth and innovation. “Joining Royal Agrifirm Group allows us to accelerate our development, expand our global reach and continue delivering high-digestibility solutions that support young animal health. This step creates exciting new opportunities for both our customers and our employees,” he said.
After closing, Hamlet Protein will continue operating under its own name as part of Royal Agrifirm Group. Both organizations will work closely together to combine their capabilities and further strengthen differentiated nutritional concepts for their valued customers in the global feed industry.